Totally implantable vascular access in treatment of cystic fibrosis

SNP discovery and genetic mapping of T-DNA insertional mutants in Fragaria vesca L.

TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik·2010

The cost of conserving livestock diversity? Incentive measures and conservation options for maintaining indigenous Pelón pigs in Yucatan, Mexico.

Tropical animal health and production·2007

Microangiopathic haemolytic anaemia secondary to lupus nephritis: an important differential diagnosis of thrombotic thrombocytopenic purpura.

Lupus·2007

Regression of post-transplant Kaposi's sarcoma using sirolimus.

International journal of clinical practice·2006

Methicillin-resistant Staphylococcus aureus in children with cystic fibrosis: An eradication protocol.

Pediatric pulmonology·2003

Renal function following pregnancy in renal transplant recipients.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology·2003

Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China.

Lancet (London, England)·2026

Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial.

Lancet (London, England)·2026

Izalontamab brengitecan for HR+/HER2- breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial.

Lancet (London, England)·2026

First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trial.

Lancet (London, England)·2026

Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China.

Lancet (London, England)·2026

14-day versus 28-day trifluridine-tipiracil plus bevacizumab for refractory metastatic colorectal cancer (PRABITAS): a pragmatic, multicentre, open-label, randomised, phase 3, non-inferiority trial in Japan.

Lancet (London, England)·2026

RGD Peptide-Functionalized CMC Hydrogel Enhances Skin Wound Repair in Mice.

Molecules (Basel, Switzerland)·2026

Flocculent Ti3AlC2-Based Two-Dimensional Material Flexible Microneedle Patch for Screening Alzheimer's Disease Animal Biomarkers and In Situ Revealing Spatial Aggregation of Arachidonic Acid.

Molecules (Basel, Switzerland)·2026

Hemicyanine-Based Wash-Free Near-Infrared Fluorescent Probe for Imaging Amyloid-β Aggregates in Alzheimer's Disease.

Molecules (Basel, Switzerland)·2026

AIDCare: A Technical Proof-of-Concept for Integrating Personalized Nutrition, Physical Activity, and AI-Assisted Care in Diabetes Lifestyle Management.

Nutrients·2026

Coronary Drug-Coated Balloons as Brief-Contact Drug-Delivery Platforms: Engineering, Tissue Pharmacokinetics, and Angiographic/Imaging Response.

Medicina (Kaunas, Lithuania)·2026

Do Gastric Balloons Have a Future? Intragastric Balloons in the Era of Highly Effective Obesity Pharmacotherapy.

Medicina (Kaunas, Lithuania)·2026

Related Experiment Videos

Totally implantable vascular access in treatment of cystic fibrosis

Related Concept Videos

SNP discovery and genetic mapping of T-DNA insertional mutants in Fragaria vesca L.

The cost of conserving livestock diversity? Incentive measures and conservation options for maintaining indigenous Pelón pigs in Yucatan, Mexico.

Microangiopathic haemolytic anaemia secondary to lupus nephritis: an important differential diagnosis of thrombotic thrombocytopenic purpura.

Regression of post-transplant Kaposi's sarcoma using sirolimus.

Methicillin-resistant Staphylococcus aureus in children with cystic fibrosis: An eradication protocol.

Renal function following pregnancy in renal transplant recipients.

Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China.

Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial.

Izalontamab brengitecan for HR+/HER2- breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial.

First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trial.

Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China.

14-day versus 28-day trifluridine-tipiracil plus bevacizumab for refractory metastatic colorectal cancer (PRABITAS): a pragmatic, multicentre, open-label, randomised, phase 3, non-inferiority trial in Japan.

RGD Peptide-Functionalized CMC Hydrogel Enhances Skin Wound Repair in Mice.

Flocculent Ti3AlC2-Based Two-Dimensional Material Flexible Microneedle Patch for Screening Alzheimer's Disease Animal Biomarkers and In Situ Revealing Spatial Aggregation of Arachidonic Acid.

Hemicyanine-Based Wash-Free Near-Infrared Fluorescent Probe for Imaging Amyloid-β Aggregates in Alzheimer's Disease.

AIDCare: A Technical Proof-of-Concept for Integrating Personalized Nutrition, Physical Activity, and AI-Assisted Care in Diabetes Lifestyle Management.

Coronary Drug-Coated Balloons as Brief-Contact Drug-Delivery Platforms: Engineering, Tissue Pharmacokinetics, and Angiographic/Imaging Response.

Do Gastric Balloons Have a Future? Intragastric Balloons in the Era of Highly Effective Obesity Pharmacotherapy.

Related Experiment Videos

Totally implantable vascular access in treatment of cystic fibrosis

Related Concept Videos

Related Articles